Search
About
Our Story
Who We Are
Leadership Team
Board of Directors
Pipeline
Overview
Publications
News & Events
Press Releases
Media Coverage
Investors
Overview
Stock Quote & Chart
Historical Stock Quote
Investment Calculator
Press Release
Event Calendar
SEC Filings
Corporate Governance
Leadership Team
Board of Directors
Committee Composition
FAQs
Investor Alerts
Investor Contacts
Investor Presentations
Careers
Contact
Search for:
News & Events
About
Our Story
Who We Are
Leadership Team
Board of Directors
Pipeline
Overview
Publications
News & Events
Press Releases
Media Coverage
Investors
Overview
Stock Quote & Chart
Historical Stock Quote
Investment Calculator
Press Release
Event Calendar
SEC Filings
Corporate Governance
Leadership Team
Board of Directors
Committee Composition
FAQs
Investor Alerts
Investor Contacts
Investor Presentations
Careers
Contact
Upcoming Events
There are no upcoming events at this time
Recent Press Releases
Jul 16, 2024
Organovo Highlights FXR314 Near Term Value Catalysts at Jones Trading Conference Strong Preclinical and Human Rationale for FXR314 in P2 2 Ulcerative Colitis
May 21, 2024
Organovo Data Presented at Digestive Disease Week (DDW2024) Demonstrating Potential for FXR314 as Combination Therapy with Tofacitinib for Inflammatory Bowel Disease
Recent Media
May 6, 2019
Organovo: Bioprinting Could be the New Solution to Organ Transplantation
Oct 19, 2018
3D Method Uses Patients' Own Cells to Repair Tissue Damage
About
Our Story
Who We Are
Leadership Team
Board of Directors
Pipeline
Overview
Publications
News & Events
Press Releases
Media Coverage
Investors
Overview
Stock Quote & Chart
Historical Stock Quote
Investment Calculator
Press Release
Event Calendar
SEC Filings
Corporate Governance
Leadership Team
Board of Directors
Committee Composition
FAQs
Investor Alerts
Investor Contacts
Investor Presentations
Careers
Contact